Onivyde savings card: as little as $0 a prescription with commercial insurance

Onivyde is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How to pay the least

Given by your care team

Billed by the clinic

Onivyde is given by a doctor or nurse, not picked up at a pharmacy.

Ask your care team or your plan what you’d pay before your visit.

Compare every option

Brand nameOnivyde

Authorized genericirinotecan

Regular genericirinotecan

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Onivyde?

The original

–

Brand nameThe maker’s card

Onivyde Copay Assistance Program (IPSEN CARES)

Savings card from Ipsen

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a prescription

In the maker’s words

“If you have been prescribed Onivyde and you have commercial (private) insurance, you may be eligible to receive copay assistance and pay as little as $0 per prescription for Onivyde.”

From the maker’s offer on ipsencares.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Onivyde itself, from the same company, sold without the brand name, and usually for less. For now Onivyde is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Pancreatic cancer that has spread

What the FDA label says

ONIVYDE is a topoisomerase inhibitor indicated:

in combination with oxaliplatin, fluorouracil and leucovorin, for the first-line treatment of adult patients with metastatic pancreatic adenocarcinoma,
in combination with fluorouracil and leucovorin, for the treatment of adult patients with metastatic pancreatic adenocarcinoma after disease progression following gemcitabine-based therapy.

Limitation of Use: ONIVYDE is not indicated as a single agent for the treatment of patients with metastatic pancreatic adenocarcinoma.

Source: the FDA label for Onivyde (Ipsen Biopharmaceuticals, Inc.), March 3, 2025. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to the clinic’s billing office.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/onivyde/